(OCRX) |
0 (0%) 06-28 18:07 |
Open: | |
High: | |
Low: | |
Volume: | 0 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | |
Industry: | |
Sector: |
Technical analysis | ||||
sell | buy |
Resistance 2: | 3.30 |
Resistance 1: | 2.96 |
Pivot price: | 2.74 |
Support 1: | 2.42 |
Support 2: | 2.01 |
52w High: | |
52w Low: |
EPS | -20590000.000 |
Book Value | 0.000 |
PEG Ratio | 0.00 |
Gross Profit | 18.718 |
Profit Margin (%) | 0.00 |
Operating Margin (%) | -1.00 |
Return on Assets (ttm) | 610.8 |
Return on Equity (ttm) | -15.9 |
Fri, 23 Feb 2024
Improving the interoperability of drugs terminologies: Infusing local standardization with an international perspective - ScienceDirect.com
Mon, 01 May 2023
Textify - find in text by Yahia Alhejoj - AppAdvice
Mon, 24 Jun 2019
Stiffer fines for parking offences, such as tailgating at carparks, from July 1 - The Straits Times
Mon, 24 Jun 2019
Hour Glass co-founder Jannie Chan's appeal against bankruptcy dismissed - The Straits Times
Thu, 02 Nov 2017
Mallinckrodt To Acquire Ocera Therapeutics And OCR-002, Its Proprietary Therapy In Development For Treatment Of ... - PR Newswire
Thu, 21 Sep 2017
Yet another tiny biotech rocket; Ocera Therapeutics up 24% (NASDAQ:OCRX) - Seeking Alpha
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |